Co-Diagnostics, Inc.
CODX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13,034 | $9,277 | $9,922 | $24,790 |
| - Cash | $11,444 | $11,115 | $1,903 | $2,937 |
| + Debt | $1,472 | $1,704 | $1,931 | $2,152 |
| Enterprise Value | $3,063 | -$134 | $9,950 | $24,006 |
| Revenue | $145 | $163 | $50 | $149 |
| % Growth | -10.8% | 224% | -66.3% | – |
| Gross Profit | $119 | $131 | $29 | -$106 |
| % Margin | 81.9% | 80.3% | 57.1% | -70.8% |
| EBITDA | -$6,746 | -$7,766 | -$8,272 | -$11,550 |
| % Margin | -4,640.6% | -4,767.3% | -16,451.9% | -7,734.7% |
| Net Income | -$5,887 | -$7,730 | -$7,533 | -$11,031 |
| % Margin | -4,049.3% | -4,745% | -14,983.5% | -7,387.4% |
| EPS Diluted | -0.16 | -0.23 | -0.24 | -0.33 |
| % Growth | 30.4% | 4.2% | 27.3% | – |
| Operating Cash Flow | -$5,905 | -$8,288 | -$8,745 | -$8,231 |
| Capital Expenditures | -$75 | -$401 | -$92 | -$73 |
| Free Cash Flow | -$5,980 | -$8,689 | -$8,837 | -$8,304 |